Couldn't load this record
The USPTO API returned an error (HTTP 429) — please try again shortly.
Patent Application
Utility
Small
App. No. 10/694,634
· Confirmation No. 2636
Methods and compounds for disruption of CD40R/CD40L signaling in the treatment of alzheimer's disease
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
No downloadable documents found — record may not be publicly available.
Inventors
Attorneys & Agents of Record
Classification
USPC
800/3
G01N33/5023
G01N33/5041
G01N33/6896
G01N2333/70578
G01N2800/2821
Prosecution
- Examiner
- POPA, ILEANA
- Art Unit
- 1633
- Customer No.
- 65989
- Docket No.
- 12062.105020
- Confirmation No.
- 2636
Publication
- Pub. No.
- US20040146949A1
- Pub. Date
- 2004-07-29
from
AIA AMERICA, INC.
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2017-02-13
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS
Recorded 2017-02-13
NUNC PRO TUNC ASSIGNMENT
Recorded 2007-05-24
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2005-01-28
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 10/694,634
- Filed
- 2003-10-27
- Pub. No.
- US20040146949A1
- Examiner
- POPA, ILEANA
- Art Unit
- 1633
External Links